Monogram Begin Period Cash Flow vs Stock Based Compensation Analysis

MGRM Stock

2.66 0.09 3.50%

Monogram Orthopaedics financial indicator trend analysis is infinitely more than just investigating Monogram Orthopaedics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Monogram Orthopaedics is a good investment. Please check the relationship between Monogram Orthopaedics Begin Period Cash Flow and its Stock Based Compensation accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Monogram Orthopaedics Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Begin Period Cash Flow vs Stock Based Compensation

Begin Period Cash Flow vs Stock Based Compensation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Monogram Orthopaedics Begin Period Cash Flow account and Stock Based Compensation. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Monogram Orthopaedics' Begin Period Cash Flow and Stock Based Compensation is 0.58. Overlapping area represents the amount of variation of Begin Period Cash Flow that can explain the historical movement of Stock Based Compensation in the same time period over historical financial statements of Monogram Orthopaedics Common, assuming nothing else is changed. The correlation between historical values of Monogram Orthopaedics' Begin Period Cash Flow and Stock Based Compensation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Begin Period Cash Flow of Monogram Orthopaedics Common are associated (or correlated) with its Stock Based Compensation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Stock Based Compensation has no effect on the direction of Begin Period Cash Flow i.e., Monogram Orthopaedics' Begin Period Cash Flow and Stock Based Compensation go up and down completely randomly.

Correlation Coefficient

0.58

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Most indicators from Monogram Orthopaedics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Monogram Orthopaedics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Monogram Orthopaedics Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

As of the 15th of December 2024, Selling General Administrative is likely to grow to about 4.3 M, while Issuance Of Capital Stock is likely to drop about 12.3 M.

	2021	2023	2024 (projected)
Interest Expense	21.7K	19.5K	18.5K
Depreciation And Amortization	322.0K	412.3K	433.0K

Interest Expense Depreciation And Amortization

Monogram Orthopaedics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Short Term Debt	Net Tangible Assets	Current Deferred Revenue	Long Term Debt	Other Current Assets	Net Invested Capital	Property Plant And Equipment Gross	Short Long Term Debt
Total Assets		-0.5	0.49	0.76	0.94	0.92	-1.0	-0.99	0.88	1.0	0.88	1.0	-0.89	-0.63	0.98	0.74	1.0	0.93	-0.92	0.88	-0.17	-0.74	0.83	0.89	0.96	-0.74
Short Long Term Debt Total	-0.5		-0.46	-0.27	-0.49	-0.56	0.54	0.48	-0.26	-0.45	-0.64	-0.45	0.32	-0.02	-0.48	-0.31	-0.47	-0.41	0.7	-0.68	-0.03	0.2	-0.69	-0.39	-0.58	0.2
Other Current Liab	0.49	-0.46		0.88	0.2	0.59	-0.48	-0.44	0.05	0.43	0.78	0.43	-0.05	-0.39	0.38	0.9	0.45	0.16	-0.65	0.6	0.75	0.14	0.46	0.05	0.54	0.14
Total Current Liabilities	0.76	-0.27	0.88		0.5	0.75	-0.72	-0.71	0.43	0.72	0.87	0.72	-0.42	-0.7	0.66	0.99	0.73	0.5	-0.77	0.71	0.46	-0.24	0.59	0.39	0.72	-0.24
Total Stockholder Equity	0.94	-0.49	0.2	0.5		0.83	-0.95	-0.94	0.95	0.96	0.72	0.96	-0.97	-0.52	0.97	0.48	0.96	0.99	-0.83	0.8	-0.47	-0.87	0.81	0.98	0.89	-0.87
Property Plant And Equipment Net	0.92	-0.56	0.59	0.75	0.83		-0.93	-0.89	0.71	0.9	0.93	0.9	-0.75	-0.63	0.87	0.73	0.91	0.8	-0.93	0.95	-0.05	-0.47	0.89	0.75	0.98	-0.47
Net Debt	-1.0	0.54	-0.48	-0.72	-0.95	-0.93		0.99	-0.88	-0.99	-0.87	-0.99	0.89	0.57	-0.99	-0.71	-1.0	-0.94	0.91	-0.88	0.19	0.73	-0.83	-0.9	-0.97	0.73
Retained Earnings	-0.99	0.48	-0.44	-0.71	-0.94	-0.89	0.99		-0.91	-0.99	-0.84	-0.99	0.91	0.54	-1.0	-0.7	-0.99	-0.94	0.87	-0.81	0.19	0.76	-0.76	-0.9	-0.95	0.76
Accounts Payable	0.88	-0.26	0.05	0.43	0.95	0.71	-0.88	-0.91		0.91	0.58	0.91	-0.98	-0.47	0.94	0.4	0.9	0.97	-0.67	0.62	-0.53	-0.93	0.62	0.98	0.8	-0.93
Cash	1.0	-0.45	0.43	0.72	0.96	0.9	-0.99	-0.99	0.91		0.84	1.0	-0.91	-0.6	0.99	0.71	1.0	0.95	-0.88	0.84	-0.22	-0.78	0.79	0.91	0.95	-0.78
Non Current Assets Total	0.88	-0.64	0.78	0.87	0.72	0.93	-0.87	-0.84	0.58	0.84		0.84	-0.6	-0.65	0.81	0.85	0.85	0.69	-0.97	0.92	0.19	-0.36	0.87	0.6	0.91	-0.36
Cash And Short Term Investments	1.0	-0.45	0.43	0.72	0.96	0.9	-0.99	-0.99	0.91	1.0	0.84		-0.91	-0.6	0.99	0.71	1.0	0.95	-0.88	0.84	-0.22	-0.78	0.79	0.91	0.95	-0.78
Common Stock Shares Outstanding	-0.89	0.32	-0.05	-0.42	-0.97	-0.75	0.89	0.91	-0.98	-0.91	-0.6	-0.91		0.52	-0.93	-0.38	-0.91	-0.99	0.7	-0.67	0.56	0.89	-0.69	-0.98	-0.82	0.89
Non Current Liabilities Total	-0.63	-0.02	-0.39	-0.7	-0.52	-0.63	0.57	0.54	-0.47	-0.6	-0.65	-0.6	0.52		-0.54	-0.6	-0.61	-0.55	0.64	-0.64	0.07	0.32	-0.66	-0.45	-0.55	0.32
Other Stockholder Equity	0.98	-0.48	0.38	0.66	0.97	0.87	-0.99	-1.0	0.94	0.99	0.81	0.99	-0.93	-0.54		0.65	0.99	0.97	-0.86	0.8	-0.27	-0.82	0.77	0.94	0.93	-0.82
Total Liab	0.74	-0.31	0.9	0.99	0.48	0.73	-0.71	-0.7	0.4	0.71	0.85	0.71	-0.38	-0.6	0.65		0.71	0.47	-0.75	0.68	0.51	-0.22	0.55	0.36	0.71	-0.22
Total Current Assets	1.0	-0.47	0.45	0.73	0.96	0.91	-1.0	-0.99	0.9	1.0	0.85	1.0	-0.91	-0.61	0.99	0.71		0.95	-0.9	0.86	-0.21	-0.77	0.81	0.91	0.95	-0.77
Common Stock	0.93	-0.41	0.16	0.5	0.99	0.8	-0.94	-0.94	0.97	0.95	0.69	0.95	-0.99	-0.55	0.97	0.47	0.95		-0.79	0.75	-0.49	-0.89	0.76	0.99	0.87	-0.89
Short Term Debt	-0.92	0.7	-0.65	-0.77	-0.83	-0.93	0.91	0.87	-0.67	-0.88	-0.97	-0.88	0.7	0.64	-0.86	-0.75	-0.9	-0.79		-0.97	0.01	0.51	-0.95	-0.72	-0.92	0.51
Net Tangible Assets	0.88	-0.68	0.6	0.71	0.8	0.95	-0.88	-0.81	0.62	0.84	0.92	0.84	-0.67	-0.64	0.8	0.68	0.86	0.75	-0.97		-0.07	-0.45	0.97	0.7	0.91	-0.45
Current Deferred Revenue	-0.17	-0.03	0.75	0.46	-0.47	-0.05	0.19	0.19	-0.53	-0.22	0.19	-0.22	0.56	0.07	-0.27	0.51	-0.21	-0.49	0.01	-0.07		0.64	-0.21	-0.58	-0.11	0.64
Long Term Debt	-0.74	0.2	0.14	-0.24	-0.87	-0.47	0.73	0.76	-0.93	-0.78	-0.36	-0.78	0.89	0.32	-0.82	-0.22	-0.77	-0.89	0.51	-0.45	0.64		-0.48	-0.92	-0.58	1.0
Other Current Assets	0.83	-0.69	0.46	0.59	0.81	0.89	-0.83	-0.76	0.62	0.79	0.87	0.79	-0.69	-0.66	0.77	0.55	0.81	0.76	-0.95	0.97	-0.21	-0.48		0.71	0.85	-0.48
Net Invested Capital	0.89	-0.39	0.05	0.39	0.98	0.75	-0.9	-0.9	0.98	0.91	0.6	0.91	-0.98	-0.45	0.94	0.36	0.91	0.99	-0.72	0.7	-0.58	-0.92	0.71		0.83	-0.92
Property Plant And Equipment Gross	0.96	-0.58	0.54	0.72	0.89	0.98	-0.97	-0.95	0.8	0.95	0.91	0.95	-0.82	-0.55	0.93	0.71	0.95	0.87	-0.92	0.91	-0.11	-0.58	0.85	0.83		-0.58
Short Long Term Debt	-0.74	0.2	0.14	-0.24	-0.87	-0.47	0.73	0.76	-0.93	-0.78	-0.36	-0.78	0.89	0.32	-0.82	-0.22	-0.77	-0.89	0.51	-0.45	0.64	1.0	-0.48	-0.92	-0.58

Click cells to compare fundamentals

Monogram Orthopaedics Account Relationship Matchups

Monogram Orthopaedics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.6M	8.1M	8.7M	13.7M	16.6M	17.4M
Short Long Term Debt Total	2.1M	205.5K	211.5K	610.2K	492.0K	777.0K
Other Current Liab	229.2K	2.7M	4.6M	8.3M	227.7K	216.3K
Total Current Liabilities	2.8M	3.0M	5.1M	9.0M	2.8M	4.0M
Total Stockholder Equity	(274.6K)	5.0M	3.5M	4.1M	13.4M	14.1M
Property Plant And Equipment Net	235.7K	989.3K	695.2K	1.1M	1.4M	765.2K
Net Debt	(195.4K)	(5.4M)	(5.3M)	(9.9M)	(13.1M)	(12.4M)
Retained Earnings	(3.2M)	(12.3M)	(24.1M)	(37.8M)	(51.5M)	(48.9M)
Accounts Payable	250.4K	182.8K	449.0K	663.2K	2.5M	2.6M
Cash	2.3M	5.6M	5.5M	10.5M	13.6M	14.3M
Non Current Assets Total	235.7K	1.7M	2.2M	2.4M	2.0M	1.4M
Cash And Short Term Investments	2.3M	5.6M	5.5M	10.5M	13.6M	14.3M
Liabilities And Stockholders Equity	2.6M	8.1M	8.7M	13.7M	16.6M	17.4M
Non Current Liabilities Total	48K	147.9K	118.6K	492.0K	363.7K	274.0K
Other Stockholder Equity	2.9M	17.2M	27.6M	41.9M	64.9M	68.1M
Total Liab	2.9M	3.1M	5.2M	9.5M	3.2M	4.3M
Total Current Assets	2.4M	6.4M	6.5M	11.3M	14.6M	15.3M
Short Term Debt	2.1M	57.5K	92.9K	118.2K	128.3K	121.9K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Monogram Orthopaedics is a strong investment it is important to analyze Monogram Orthopaedics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Monogram Orthopaedics' future performance. For an informed investment choice regarding Monogram Stock, refer to the following important reports:

How To Invest In Monogram

Details

Is Monogram Stock a good investment?

Details

What is Monogram Orthopaedics' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Monogram Orthopaedics Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Monogram Orthopaedics. If investors know Monogram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Monogram Orthopaedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.47)

Revenue Per Share

0.012

Return On Assets

(0.61)

Return On Equity

(1.22)

The market value of Monogram Orthopaedics is measured differently than its book value, which is the value of Monogram that is recorded on the company's balance sheet. Investors also form their own opinion of Monogram Orthopaedics' value that differs from its market value or its book value, called intrinsic value, which is Monogram Orthopaedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Monogram Orthopaedics' market value can be influenced by many factors that don't directly affect Monogram Orthopaedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Monogram Orthopaedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Monogram Orthopaedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Monogram Orthopaedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Monogram Begin Period Cash Flow vs Stock Based Compensation Analysis

Begin Period Cash Flow vs Stock Based Compensation

Begin Period Cash Flow vs Stock Based Compensation Correlation Analysis

Correlation Coefficient

Begin Period Cash Flow

Stock Based Compensation

Monogram Orthopaedics fundamental ratios Correlations

Monogram Orthopaedics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Monogram Orthopaedics fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments

Other Stockholder Equity	- 1.0	Retained Earnings
Total Current Assets	- 1.0	Net Debt
Net Debt	- 1.0	Total Assets
Common Stock	- 0.99	Common Stock Shares Outstanding
Total Current Assets	- 0.99	Retained Earnings
Cash And Short Term Investments	- 0.99	Retained Earnings